WTSIi051-A
HPSI1113i-uofv_1
iPSC line
At European Collection of Authenticated Cell Cultures (ECACC)
A CLIP contains information about a cell line including any
specific third party obligations relating to, for example,
licensing obligations or the donor consent which affect the
use of the cell line.
A batch specific Certificate of Analysis will be available to
download once you receive your EBiSC iPSC line.
General#
Cell Line |
|
hPSCreg Name | WTSIi051-A |
Alternative name(s) |
HPSI1113i-uofv_1
|
Cell line type | Human induced pluripotent stem cell (hiPSC) |
Similar lines |
WTSIi002-A (HPSI0913i-eika_2) WTSIi004-A (HPSI1113i-qolg_3) WTSIi006-A (HPSI1113i-hayt_1) WTSIi008-A (HPSI1013i-kuxp_1) WTSIi010-A (HPSI0314i-xugn_1) WTSIi013-A (HPSI0214i-kucg_2) WTSIi014-A (HPSI0214i-heja_2) WTSIi016-A (HPSI0114i-oevr_3) WTSIi018-A (HPSI0114i-kolf_3) WTSIi019-A (HPSI0114i-iisa_3) WTSIi022-A (HPSI1013i-yemz_1) WTSIi023-A (HPSI0114i-zapk_3) WTSIi025-A (HPSI1013i-pamv_1) WTSIi031-A (HPSI0314i-bipt_1) WTSIi032-A (HPSI1113i-bima_1) WTSIi039-A (HPSI1013i-wopl_1) WTSIi042-A (HPSI1013i-jufd_2) WTSIi014-B (HPSI0214i-heja_1) WTSIi010-B (HPSI0314i-xugn_2) WTSIi025-B (HPSI1013i-pamv_3) WTSIi004-B (HPSI1113i-qolg_1) WTSIi022-B (HPSI1013i-yemz_3) WTSIi006-B (HPSI1113i-hayt_3) WTSIi019-B (HPSI0114i-iisa_1) WTSIi050-A (HPSI1014i-toss_3) WTSIi053-A (HPSI0413i-corn_1) WTSIi054-A (HPSI0413i-nudd_1) WTSIi064-A (HPSI0613i-bohf_1) WTSIi065-A (HPSI0613i-eojr_2) WTSIi068-A (HPSI0613i-giuo_5) WTSIi070-A (HPSI0713i-terl_1) WTSIi072-A (HPSI0114i-fikt_3) WTSIi065-B (HPSI0613i-eojr_3) WTSIi070-B (HPSI0713i-terl_2) WTSIi042-B (HPSI1013i-jufd_3) WTSIi078-A (HPSI0314i-fafq_1) WTSIi079-A (HPSI1013i-hiaf_2) WTSIi081-A (HPSI1113i-qorq_2) WTSIi084-A (HPSI0713i-cicb_3) WTSIi090-A (HPSI0813i-robp_3) WTSIi091-A (HPSI0813i-ffdc_11) WTSIi092-A (HPSI0713i-nemb_1) WTSIi093-A (HPSI0413i-sukz_1) WTSIi095-A (HPSI0813i-vajx_2) WTSIi101-A (HPSI0513i-fejf_2) WTSIi106-A (HPSI0613i-hikj_2) WTSIi107-A (HPSI0813i-iill_1) WTSIi081-B (HPSI1113i-qorq_1) WTSIi084-B (HPSI0713i-cicb_2) WTSIi107-B (HPSI0813i-iill_3) |
Provider |
|
Depositor | Wellcome Sanger Institute (WTSI) |
Distributors |
EBiSC
European Collection of Authenticated Cell Cultures (ECACC)
|
Derivation country | United Kingdom |
External Databases |
|
hPSCreg | WTSIi051-A |
BioSamples | SAMEA2464819 |
HipSci | HPSI1113i-uofv_1 |
Cellosaurus | CVCL_AE07 |
ECACC | 77650078, 66540151 |
CLO | CLO_0101017 |
Wikidata | Q54891659 |
General Information |
|
Publications | View all related publications on hPSCreg (1) |
* Is the cell line readily obtainable for third parties? |
Yes Research use: allowed
Clinical use: not allowed
Commercial use: not allowed
|
Donor Information#
General Donor Information |
|
Sex | male |
Age of donor (at collection) | 60-64 |
Ethnicity | White - White British |
Phenotype and Disease related information (Donor) |
|
Diseases | No disease was diagnosed.
|
External Databases (Donor) |
|
BioSamples | SAMEA2399022 |
HipSci | HPSI-uofv |
hIPSC Derivation#
General |
|
Source cell type |
fibroblastA connective tissue cell which secretes an extracellular matrix rich in collagen and other macromolecules. Flattened and irregular in outline with branching processes; appear fusiform or spindle-shaped.
|
Source cell origin |
zone of skinAny portion of the organ that covers that body and consists of a layer of epidermis and a layer of dermis.
|
Age of donor (at collection) | 60-64 |
Collected in | 2014 |
Source cell line vendor | Cambridge BioResource |
Reprogramming method |
|
Vector type | Non-integrating |
Vector | Sendai virus |
Genes | |
Notes on reprogramming vector detection | CytoTune 1 |
Vector free reprogramming |
|
Other |
|
Selection criteria for clones | Morphology |
Derived under xeno-free conditions |
No |
Derived under GMP? |
No |
Available as clinical grade? |
No |
Culture Conditions#
Latest released batch |
|
Passage method | EDTA |
Surface coating | Vitronectin |
O2 concentration | 21 |
CO2 concentration | 5 |
Temperature | 37 |
The following are the depositor culture conditions, they do not refer to any specific batch.
Surface coating | Vitronectin |
Feeder cells |
No |
Passage method |
Enzyme-free cell dissociation
EDTA
|
CO2 Concentration | 5 % |
Medium |
TeSR™ E8™
|
Characterisation#
Analysis of Undifferentiated Cells
Marker | Expressed | Immunostaining | RT-PCR | FACS | Enzymatic Assay | Expression Profiles |
POU5F1 (OCT-4) |
Yes |
|
|
|||
SOX2 |
Yes |
|
||||
NANOG |
Yes |
|
||||
SSEA-1 |
No |
|
||||
SSEA-4 |
Yes |
|
||||
TRA 1-60 |
Yes |
|
Pluripotency Score | Novelty Score | Link to microarray data |
37.517 | 1.369 | http://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-4057/ |
Report
HPSI-uofv.pluritest.pluripotency_score.20161010.png
pluripotency image
HPSI-uofv.pluritest.novelty_score.20161010.png
novelty image
Microbiology / Virus Screening |
|
HIV 1 | Negative |
HIV 2 | Negative |
Hepatitis B | Negative |
Hepatitis C | Negative |
Mycoplasma | Negative |
Sterility |
|
Inoculation for microbiological growth | No Contaminants Detected |
Mycoplasma | Not Detected |
Viability | Viable post-cryopreservation |
Genotyping#
Karyotyping (Cell Line) |
|
Has the cell line karyotype been analysed? |
No
|
Other Genotyping (Cell Line) |
|
Is there genome-wide genotyping or functional data available? |
Yes
Exome sequencing
http://www.ebi.ac.uk/ena/data/view/ERZ122980
cnv
http://www.hipsci.org/lines/#/lines/HPSI1113i-uofv_1 Number of regions different from primary tissue: 2; Length of differences from primary tissue: 1
Methylation profiling
http://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-4059/ Text file with probe intensities |
WGS-derived disease associations |
3-hydroxyisobutyryl-CoA hydrolase deficiency (HIBCH)
Charcot-Marie-Tooth disease (FIG4)
Cohen syndrome (VPS13B)
complex neurodevelopmental disorder (CNTNAP2, SETBP1)
dilated cardiomyopathy (MIB1)
factor XIII, b subunit, deficiency of (F13B)
familial thoracic aortic aneurysm and aortic dissection (MFAP5)
Fanconi anemia complementation group A (FANCA)
galactosemia (GALT)
hereditary nonpolyposis colon cancer (XRCC4)
Leigh syndrome (HIBCH)
Lynch syndrome (PMS1)
mitochondrial disease (NDUFS6)
monogenic diabetes (PAX4)
mucopolysaccharidosis type 4A (GALNS)
nephronophthisis 4 (NPHP4)
nonsyndromic genetic hearing loss (CDH23, LOXHD1, MYO7A)
PHARC syndrome (ABHD12)
primary ciliary dyskinesia 7 (DNAH11)
renal tubular acidosis, distal, 2, with progressive sensorineural hearing loss (ATP6V1B1)
Rothmund-Thomson syndrome (RECQL4)
Schinzel-Giedion syndrome (SETBP1)
syndromic intellectual disability (KMT2C)
turnpenny-fry syndrome (PCGF2)
Usher syndrome type 1 (CDH23, MYO7A)
vitamin K-dependent clotting factors, combined deficiency of, type 2 (VKORC1)
|
Other WGS-derived genes | AGL, AGXT2, AKR1E2, ALDH3A2, ALDOB, AMPD1, ATXN3, AURKC, B3GAT3, BMP4, CASP12, CNOT1, COLQ, D2HGDH, DNAAF1, DNAJA4, DSC3, FLG, GDPD4, GLYCTK, HEY1, IDO2, IRF5, ITGB2, KCNJ16, KLHL3, KRT18, LPL, MED15, MICA, MROH8, NDUFB9, NPRL3, OAS1, OR51F1, P2RX5, PDE4DIP, PIGN, PITX2, POLDIP2, PRKRA, PTCHD3, PYGL, SCAPER, SIGLEC12, SLC37A4, SPATA7, SYNE2, TGIF1, TIGD6, TMEM107, TMEM216, TMPRSS6, TNRC18, TREH, TRPM1, UGT2A1, VDR, WDR37, ZAN, ZNF141, ZNF233, ZNF527, ZNF83 |